-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
-
Summary
-
Kinnate Biopharma Inc. quarterly/annual Operating Lease, Payments history and change rate from Q1 2022 to 2023.
- Kinnate Biopharma Inc. Operating Lease, Payments for the quarter ending March 31, 2023 was $300K.
- Kinnate Biopharma Inc. annual Operating Lease, Payments for 2023 was $1.2M, a 100% increase from 2022.
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, Annual (USD)
Operating Lease, Payments, YoY Annual Change (%)